The End of Cancer: DCA makes its world debut.

A host of mitochondria together provide every human cell with energy for all of the processes necessary for life.

Mitochondria however are also ironically responsible for cell aging and ultimately cell death. Cancer cells are able to skip the functions of the mitochondria by exploiting glycolysis as their mode of energy production, which unlike the mitochondria does not use oxygen in its energy-releasing glucose breakdown.

The result is not only the avoidance of cell aging and cell death by snubbing the mitochondria, but the cancer cells also acquire the corrosive ability of lactic acid (a by-product of glycolysis), that helps them eat through tissue and take over the human body at an even more alarming rate.

As outlined in the image above, the DCA reactivates the dormant mitochondria in cancer cells, so that the cancer cells age and eventually die like all other cells.

The DCA’s mode of operation is basically just that simple.

And just as simple would be its availability and cost if it were perfected and introduced in the medical field as soon as possible. According to the University of Alberta, tumour cells extracted from forty-nine brain tumour patients were subjected to DCA treatments and these tumours showed remarkable and desirable changes in their metabolism.

The research team also gave the DCA treatment to five patients whose tumours regressed over three months or at the very least remained constant in size while exhibiting no signs of growth.

The lack of media attention to this century’s eureka moment is startling and begs to be remedied. To the millions of cancer patients worldwide and their grieving families, Dr. Michelakis’ research breathes new and unprecedented hope into a bleak future.

With adequate funding and social awareness the DCA project could well put a close to the leading cause of death in North America. On the other hand, if DCA is not the rosy solution to cancer (as many critics believe it not to be), the research related to DCA may spur other cancer-research groups to pursue the end of cancer with greater vigour.

Either way, the end of cancer appears nearer than it did a decade ago and it is about time scientists and medical teams alike made cancer old news.

First published in May 22, 2011

ARB Team
Arbitrage Magazine
Business News with BITE.

Liked this post? Why not buy the ARB team a beer? Just click an ad or donate below (thank you!)

Liked this article? Hated it? Comment below and share your opinions with other ARB readers!